Biological Markers and Guided Therapy

Vol. 3, 2016, no. 1, 23-31

Borys B. Samura
      Galectin-3 as predictor of higher statin treatment efficacy in patients with chronic lymphocytic leukemia
      Biological Markers and Guided Therapy, Vol. 3, 2016, no. 1, 23-31
      http://dx.doi.org/10.12988/bmgt.2016.613

Copyright © 2016 Borys B. Samura. This article is distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.